Impact of inflammation on vascular disease in hypertension.

[1]  E. Schiffrin.  Immune mechanisms in hypertension and vascular injury. , 2014, Clinical science.

[2]  E. Porteri,et al.  Immune Mechanisms in Hypertension , 2014, High Blood Pressure & Cardiovascular Prevention.

[3]  E. Schiffrin.  Immune mechanisms in hypertension: how do T-regulatory lymphocytes fit in? , 2013, Journal of hypertension.

[4]  M. Trebak,et al.  CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension , 2013, Journal of hypertension.

[5]  Y. Jang,et al.  Immunosenescent CD8+ T Cells and C-X-C Chemokine Receptor Type 3 Chemokines Are Increased in Human Hypertension , 2013, Hypertension.

[6]  T. Münzel,et al.  Angiotensin II–Induced Vascular Dysfunction Depends on Interferon-&ggr;–Driven Immune Cell Recruitment and Mutual Activation of Monocytes and NK-Cells , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[7]  G. Pucci,et al.  Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study , 2013, Journal of hypertension.

[8]  S. Abbara,et al.  Arterial inflammation in patients with HIV. , 2012, JAMA.

[9]  E. Schiffrin,et al.  T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury , 2012, Hypertension.

[10]  M. Trebak,et al.  Interleukin-10 Released by CD4+CD25+ Natural Regulatory T Cells Improves Microvascular Endothelial Function Through Inhibition of NADPH Oxidase Activity in Hypertensive Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[11]  M. D. de Boer,et al.  Endothelial Dysfunction and Low-Grade Inflammation Are Associated With Greater Arterial Stiffness Over a 6-Year Period , 2011, Hypertension.

[12]  A. Waisman,et al.  Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction , 2011, Circulation.

[13]  E. Schiffrin,et al.  Immune Mechanisms in Hypertension , 2011, Current hypertension reports.

[14]  Antony Vinh,et al.  Inflammation, Immunity, and Hypertension , 2011, Hypertension.

[15]  Luís Eduardo Coelho Andrade,et al.  Sistema imunitário: Parte I. Fundamentos da imunidade inata com ênfase nos mecanismos moleculares e celulares da resposta inflamatória , 2010 .

[16]  C. Vlachopoulos,et al.  Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[17]  E. Schiffrin.  T lymphocytes: a role in hypertension? , 2010, Current opinion in nephrology and hypertension.

[18]  F. Luft,et al.  Mononuclear Phagocyte System Depletion Blocks Interstitial Tonicity-Responsive Enhancer Binding Protein/Vascular Endothelial Growth Factor C Expression and Induces Salt-Sensitive Hypertension in Rats , 2010, Hypertension.

[19]  E. Schiffrin,et al.  Immune regulation and vascular inflammation in genetic hypertension. , 2010, American journal of physiology. Heart and circulatory physiology.

[20]  F. Faraci,et al.  Endogenous Interleukin-10 Inhibits Angiotensin II–Induced Vascular Dysfunction , 2009, Hypertension.

[21]  M. Young,et al.  Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure , 2009, Hypertension.

[22]  K. Alitalo,et al.  Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism , 2009, Nature Medicine.

[23]  A. Tedgui,et al.  Regulatory T‐cell immunity and its relevance to atherosclerosis , 2008, Journal of internal medicine.

[24]  M. Hughson,et al.  Interactions between oxidative stress and inflammation in salt-sensitive hypertension. , 2007, American journal of physiology. Heart and circulatory physiology.

[25]  L. Ghiadoni,et al.  C-reactive protein and hypertension: is there a causal relationship? , 2007, Current pharmaceutical design.

[26]  I. Kallikazaros,et al.  Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. , 2007, European heart journal.

[27]  E. Schiffrin,et al.  Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[28]  L. Ghiadoni,et al.  Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. , 2006, The Journal of clinical endocrinology and metabolism.

[29]  C. Vlachopoulos,et al.  Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension , 2006, Journal of hypertension.

[30]  R. Blumenthal,et al.  The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2005, Journal of the American College of Cardiology.

[31]  Azra Mahmud,et al.  Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension , 2005, Hypertension.

[32]  E. Schiffrin,et al.  Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II–Infused Macrophage Colony-Stimulating Factor–Deficient Mice: Evidence for a Role in Inflammation in Angiotensin-Induced Vascular Injury , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[33]  L. Bautista,et al.  Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension , 2005, Journal of Human Hypertension.

[34]  R. Touyz.  Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? , 2004, Hypertension.

[35]  E. Schiffrin,et al.  Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice , 2004, Journal of hypertension.

[36]  K. Griendling,et al.  Reactive oxygen species in the vasculature: molecular and cellular mechanisms. , 2003, Hypertension.

[37]  E. Schiffrin,et al.  Vascular inflammation: a role in vascular disease in hypertension? , 2003, Current opinion in nephrology and hypertension.

[38]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[39]  P. Ridker,et al.  Blood Pressure and Inflammation in Apparently Healthy Men , 2001, Hypertension.

[40]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[41]  L. Andrade,et al.  Immune system - part I. Fundamentals of innate immunity with emphasis on molecular and cellular mechanisms of inflammatory response. , 2010, Revista brasileira de reumatologia.